These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Webb OL; Laskarzewski PM; Glueck CJ Metabolism; 1984 Nov; 33(11):971-5. PubMed ID: 6493049 [TBL] [Abstract][Full Text] [Related]
7. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. Dickerman RD; McConathy WJ; Zachariah NY J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668 [TBL] [Abstract][Full Text] [Related]
8. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. Urhausen A; Torsten A; Wilfried K J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):369-75. PubMed ID: 12711025 [TBL] [Abstract][Full Text] [Related]
9. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Glazer G Arch Intern Med; 1991 Oct; 151(10):1925-33. PubMed ID: 1929679 [TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin on liver and plasma levels of cholesterol, dolichol and ubiquinol in hypercholesterolemic rats. Marinari UM; Pronzato MA; Dapino D; Gazzo P; Traverso N; Cottalasso D; Odetti P Ital J Biochem; 1995; 44(1):1-9. PubMed ID: 7797420 [TBL] [Abstract][Full Text] [Related]
11. Evolution of serum lipids in two male bodybuilders using anabolic steroids. Lajarin F; Zaragoza R; Tovar I; Martinez-Hernandez P Clin Chem; 1996 Jun; 42(6 Pt 1):970-2. PubMed ID: 8665691 [TBL] [Abstract][Full Text] [Related]
12. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Pope HG; Katz DL Arch Gen Psychiatry; 1994 May; 51(5):375-82. PubMed ID: 8179461 [TBL] [Abstract][Full Text] [Related]
13. The modulating effect of an inhibitor of cholesterolgenesis present in bovine milk upon the synthesis of cholesterol, dolichol and ubiquinone. Dull BJ; McCarthy RD; Kilara A Atherosclerosis; 1983 Dec; 49(3):231-9. PubMed ID: 6661267 [TBL] [Abstract][Full Text] [Related]
14. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541 [TBL] [Abstract][Full Text] [Related]
15. Mevalonic acid products as mediators of cell proliferation in simian virus 40-transformed 3T3 cells. Larsson O; Johansson BM Cancer Res; 1987 Sep; 47(18):4825-9. PubMed ID: 3040232 [TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin (MK-733) on branched pathway of mevalonate. Nagata Y; Hidaka Y; Ishida F; Kamei T Jpn J Pharmacol; 1990 Nov; 54(3):315-24. PubMed ID: 2090840 [TBL] [Abstract][Full Text] [Related]
17. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. Melnik B; Jansen T; Grabbe S J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777 [TBL] [Abstract][Full Text] [Related]
18. Hypothalamic digoxin mediated model for oncogenesis. Kurup RK; Nair R; Kurup PA J Exp Clin Cancer Res; 2001 Dec; 20(4):573-83. PubMed ID: 11876554 [TBL] [Abstract][Full Text] [Related]
19. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478 [TBL] [Abstract][Full Text] [Related]